Methylenedioxyallylamphetamine

From Infogalactic: the planetary knowledge core
(Redirected from MDAL)
Jump to: navigation, search
Methylenedioxyallylamphetamine
MDAL.png
Names
IUPAC name
N-[1-(1,3-benzodioxol-5-yl)propan-2-yl]prop-2-en-1-amine
Identifiers
74698-45-6 YesY
ChemSpider 21106331 N
Jmol 3D model Interactive image
  • InChI=1S/C13H17NO2/c1-3-6-14-10(2)7-11-4-5-12-13(8-11)16-9-15-12/h3-5,8,10,14H,1,6-7,9H2,2H3 N
    Key: BMKCDDFQEGYEJC-UHFFFAOYSA-N N
  • InChI=1/C13H17NO2/c1-3-6-14-10(2)7-11-4-5-12-13(8-11)16-9-15-12/h3-5,8,10,14H,1,6-7,9H2,2H3
    Key: BMKCDDFQEGYEJC-UHFFFAOYAO
  • C1=C2C(=CC=C1CC(C)NCC=C)OCO2
Properties
C13H17NO2
Molar mass 219.283 g/mol
Vapor pressure {{{value}}}
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

MDAL or 3,4-methylenedioxy-N-allylamphetamine is a lesser-known psychedelic drug. It is also the N-allyl isomer of MDA. MDAL was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines I Have Known And Loved), the minimum dosage is listed as 180 mg, and the duration unknown. MDAL produces few to no effects on its own, but may enhance the effects of LSD. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDAL.

See also

External links

<templatestyles src="Asbox/styles.css"></templatestyles>